Cargando…

Proton Pump Inhibitor-Induced Gut Dysbiosis Increases Mortality Rates for Patients with Clostridioides difficile Infection

Clostridioides difficile infection (CDI) is associated with high mortality rates among patients with chronic illnesses. We aimed to identify avoidable risk factors to reduce the mortality rate in CDI patients. A total of 306 patients with diarrhea and clinical suspicion of CDI were enrolled, and fec...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Cheng-Yu, Cheng, Hao-Tsai, Kuo, Chia-Jung, Lee, Yun-Shien, Sung, Chang-Mu, Keidan, Micah, Rao, Krishna, Kao, John Y., Hsieh, Sen-Yung
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society for Microbiology 2022
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430933/ https://www.ncbi.nlm.nih.gov/pubmed/35863023 http://dx.doi.org/10.1128/spectrum.00486-22

Ejemplares similares

Clostridioides difficile infection surveillance in intensive care units and oncology wards using machine learning
por: Ötleş, Erkin, et al.
Publicado: (2023)

17. Comparative Assessment of a Machine Learning Model and Rectal Swab Surveillance to Predict Hospital Onset Clostridioides difficile
por: Ötleş, Erkin, et al.
Publicado: (2021)

Gut Dysbiosis and Clostridioides difficile Infection in Neonates and Adults
por: Vasilescu, Iulia-Magdalena, et al.
Publicado: (2022)

2403. Clostridium difficile ribotypes and human microbiota differ in Taiwan and the United States with respect to diarrheal patients
por: Motyka, Jonathan, et al.
Publicado: (2019)

Systemic Inflammatory Mediators Are Effective Biomarkers for Predicting Adverse Outcomes in Clostridioides difficile Infection
por: Dieterle, Michael G., et al.
Publicado: (2020)

2389. Assessing the Time Course of Proton Pump Inhibitor Use and Clostridioides difficile Infection
por: Panagos, Katherine, et al.
Publicado: (2019)

Longitudinal genomic surveillance of carriage and transmission of Clostridioides difficile in an intensive care unit
por: Miles-Jay, Arianna, et al.
Publicado: (2023)

Prevalence of Clostridioides difficile in Canine Feces and Its Association with Intestinal Dysbiosis
por: Werner, Melanie, et al.
Publicado: (2023)

The Proton Pump Inhibitor Omeprazole Does Not Promote Clostridioides difficile Colonization in a Murine Model
por: Tomkovich, Sarah, et al.
Publicado: (2019)

802. Proton Pump Inhibitors Increase Clostridioides difficile Disease Severity Controlling for Infecting Strains
por: Fallatah, Saad, et al.
Publicado: (2020)

Fecal microbiota transplantation and donor screening for Clostridioides difficile infection during COVID-19 pandemic
por: Chiu, Cheng-Hsun, et al.
Publicado: (2021)

Diarrheal-associated gut dysbiosis in cancer and inflammatory bowel disease patients is exacerbated by Clostridioides difficile infection
por: Kulecka, Maria, et al.
Publicado: (2023)

54101 Characterizing Microbiota Features of Clostridioides difficile Infections
por: Tomkovich, Sarah, et al.
Publicado: (2021)

Clostridioides difficile biofilms: A mechanism of persistence in the gut?
por: Frost, Lucy R., et al.
Publicado: (2021)

2236. Stool-Derived Inflammatory Mediators Serve as Biomarkers of Severity in Clostridium difficile Infection
por: Motyka, Jonathan, et al.
Publicado: (2019)

Intestinal Dysbiosis and Risk of Posttransplant Clostridioides difficile Infection in a Longitudinal Cohort of Liver Transplant Recipients
por: Gomez-Simmonds, Angela, et al.
Publicado: (2022)

Effect of fecal microbial transplantation on Clostridioides difficile infection: dysbiosis, metabolites and health related quality of life
por: Garey, Kevin W, et al.
Publicado: (2023)

2355. The Association Between Diagnostic Testing Method and Clostridium difficile Infection Severity
por: Menon, Anitha, et al.
Publicado: (2019)

Clostridioides difficile infection: traversing host–pathogen interactions in the gut
por: Cheng, Jeffrey K. J., et al.
Publicado: (2023)

2424. Shedding of Viable Clostridiodes difficile in Patients Admitted to a Medical Intensive Care Unit
por: Young, Vincent B, et al.
Publicado: (2019)

Diagnostic Methods of Clostridioides difficile Infection and Clostridioides difficile Ribotypes in Studied Sample
por: Novakova, Elena, et al.
Publicado: (2021)

792. Evaluation of Persistent Diarrhea and Recurrence Following Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection
por: Boton, Noah, et al.
Publicado: (2020)

Proton pump inhibitors and dysbiosis: Current knowledge and aspects to be clarified
por: Bruno, Giovanni, et al.
Publicado: (2019)

Implementation of fecal microbiota transplantation in a medical center for recurrent or refractory Clostridioides difficile infection and report of preliminary outcome
por: Yeh, Yuan-Ming, et al.
Publicado: (2022)

Gut metabolites predict Clostridioides difficile recurrence
por: Dawkins, Jennifer J., et al.
Publicado: (2022)

687. Zinplava Expert Retrospective Observations (ZERO) Study Findings on Clostridioides difficile Recurrence
por: Jacobs, Micah, et al.
Publicado: (2023)

Iron Regulation in Clostridioides difficile
por: Berges, Mareike, et al.
Publicado: (2018)

Extraintestinal Clostridioides difficile infection
por: Hai, Zhao, et al.
Publicado: (2020)

Pathogenicity and virulence of Clostridioides difficile
por: Buddle, Jessica E., et al.
Publicado: (2023)

Duodenal Dysbiosis and Relation to the Efficacy of Proton Pump Inhibitors in Functional Dyspepsia
por: Wauters, Lucas, et al.
Publicado: (2021)

Bacteria Co-colonizing with Clostridioides Difficile in Two Asymptomatic Patients
por: Hong, Wei, et al.
Publicado: (2019)

2387. Learning the Influence of Individual Clostridioides difficile Infections
por: Mu, Emily, et al.
Publicado: (2019)

Fecal microbiota transplantation for treatment of refractory or recurrent Clostridioides difficile infection in Taiwan: a cost-effectiveness analysis
por: Lan, Kai-Yen, et al.
Publicado: (2023)

2409. External Validation and Comparison of Clostridioides difficile Severity Scoring Systems
por: Perry, Donald A, et al.
Publicado: (2019)

Proton pump inhibitor-induced gut dysbiosis and immunomodulation: current knowledge and potential restoration by probiotics
por: Kiecka, Aneta, et al.
Publicado: (2023)

Gut associated metabolites and their roles in Clostridioides difficile pathogenesis
por: Aguirre, Andrea Martinez, et al.
Publicado: (2022)

Microbial ecology between Clostridioides difficile and gut microbiota
por: KAMIYA, Shigeru
Publicado: (2023)

Genomic characterization of nine Clostridioides difficile strains isolated from Korean patients with Clostridioides difficile infection
por: Ahn, Seung Woo, et al.
Publicado: (2021)

A High-Carbohydrate Diet Prolongs Dysbiosis and Clostridioides difficile Carriage and Increases Delayed Mortality in a Hamster Model of Infection
por: Bhute, Shrikant S., et al.
Publicado: (2022)

Evidence for proton-pump inhibitor (PPI)-associated dysbiosis in metabolically unhealthy obesity
por: Burmeister, Melissa A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_d0gk3prsubnavpe4cr3t9v8dmo